High-risk HPV-positive and-negative high-grade cervical dysplasia: Analysis of 5-year outcomes

被引:44
|
作者
Bogani, Giorgio [1 ]
Sopracordevole, Francesco [2 ]
Di Donato, Violante [3 ]
Ciavattini, Andrea [4 ]
Ghelardi, Alessandro [5 ]
Lopez, Salvatore [1 ]
Simoncini, Tommaso [6 ]
Plotti, Francesco [7 ]
Casarin, Jvan [8 ]
Serati, Maurizio [8 ]
Pinelli, Ciro [9 ]
Valenti, Gaetano [3 ]
Bergamini, Alice [10 ]
Gardella, Barbara [11 ]
Dell'acqua, Andrea [12 ]
Monti, Ermelinda [12 ]
Vercellini, Paolo [12 ]
Fischetti, Margherita [3 ]
D'ippolito, Giovanni [13 ]
Aguzzoli, Lorenzo [13 ]
Mandato, Vincenzo D. [13 ]
Carunchio, Paola [13 ]
Carlinfante, Gabriele [13 ]
Giannella, Luca [4 ]
Scaffa, Cono [14 ]
Falcone, Francesca [14 ]
Borghi, Chiara [15 ]
Ditto, Antonino [1 ]
Malzoni, Mario [16 ]
Giannini, Andrea [17 ]
Salerno, Maria Giovanna [17 ]
Liberale, Viola [18 ]
Contino, Biagio [18 ]
Donfrancesco, Cristina [19 ]
Desiato, Michele [19 ]
Perrone, Anna Myriam [20 ]
Dondi, Giulia [20 ]
De Iaco, Pierandrea [20 ]
Chiappa, Valentina [1 ]
Ferrero, Simone [21 ,22 ]
Sarpietro, Giuseppe [23 ]
Matarazzo, Maria G. [23 ]
Cianci, Antonio [23 ]
Bosio, Sara [24 ]
Ruisi, Simona [24 ]
Guerrisi, Rocco [9 ]
Brusadelli, Claudia [9 ]
Mosca, Lavinia [25 ]
Lagana, Antonio Simone [8 ]
Tinelli, Raffaele [26 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori Milano, Gynecol Oncol Unit, Milan, Italy
[2] Natl Canc Inst, Ctr Riferimento Oncol, Gynecol Oncol Unit, Via F Gallini 2, I-33081 Aviano, Italy
[3] Sapienza Univ Rome, Dept Gynecol Obstet & Urol Sci, Rome, Italy
[4] Polytech Univ Marche, Gynecol Sect, Womans Hlth Sci Dept, Ancona, Italy
[5] Osped Apuane, Azienda Usl Toscana Nord Ovest, UOC Ostetricia & Ginecol, Massa, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[7] Campus Biomed Univ Rome, Rome, Italy
[8] Univ Insubria, Filippo Del Ponte Hosp, Dept Obstet & Gynecol, Varese, Italy
[9] Osped Circolo Fdn Macchi, Varese, Italy
[10] IRCCS Osped San Raffaele, Dept Obstet & Gynecol, Milan, Italy
[11] Univ Pavia, IRCCS S Matteo Fdn, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy
[12] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gynaecol Unit, Milan, Italy
[13] Azienda Unita Sanit Locale IRCCS Reggio Emilia, Cesare Magati Hosp, Div Obstet & Gynecol, Scandiano, Italy
[14] IRCCS Fdn G Pascale, Ist Nazl Tumori, Gynecol Oncol Unit, Naples, Italy
[15] S Anna Univ Hosp, Dept Obstet & Gynecol, Ferrara, Italy
[16] Ctr Adv Endoscop Gynecol Surg, Endoscop Malzoni, Avellino, Italy
[17] San Camillo Forlanini Hosp, Dept Womans & Childs Hlth, Obstet & Gynecol Unit, Rome, Italy
[18] Osped Maria Vittoria, Dept Obstet & Gynecol, Turin, Italy
[19] Osped S Trinita Sora, Dept Obstet & Gynecol, Azienda ASL Frosinone, Sora, Italy
[20] St Orsola Malpighi Hosp, Gynecol Oncol Unit, I-40138 Bologna, Italy
[21] IRCCS Osped Policlin San Martino, Acad Unit Obstet & Gynecol, Genoa, Italy
[22] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[23] Univ Catania, Gynecol Clin, Dept Gen Surg & Med Surg Specialties, Via S Sofia 78, I-95124 Catania, Italy
[24] Univ Milan, San Paolo Hosp, I-20142 Milan, Italy
[25] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, I-80138 Naples, Italy
[26] Valle Itria Hosp, Dept Obstet & Gynecol, Via San Francesco da Paola, I-74015 Taranto, Italy
[27] Fdn Policlin Univ A Gemelli, IRCCS, Dipartimento Salute Donna & Bambino & Salute Pubb, UOC Ginecol Oncol, Rome, Italy
[28] Univ Sassari, Gynecol & Obstet Unit, Dept Med Surg & Expt Sci, Sassari, Italy
[29] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Sch Med, Naples, Italy
关键词
HPV; Negative; Positive; CIN; Conization; CANCER; NEOPLASIA; SUBTYPES; WOMEN;
D O I
10.1016/j.ygyno.2021.01.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the outcomes of high-risk (HR) HPV-positive and-negative women affected by high-grade cervical dysplasia. Methods. This is a retrospective multi-institutional study. Medical records of consecutive patients with high-grade cervical dysplasia undergoing conization between 2010 and 2014 were retrieved. All patients included had at least 5 years of follow-up. A propensity-score matching was adopted in order to reduce the presence of con-founding factors between groups. Kaplan-Meir and Cox hazard models were used to estimate 5-year outcomes. Results. Overall, data of 2966 women, affected by high-grade cervical dysplasia were reviewed. The study population included 1478 (85%) and 260 (15%) women affected by HR-HPV-positive and HR-HPV-negative high-grade cervical dysplasia. The prevalence of CIN2 and CIN3 among the HR-HPV-positive and-negative cohort was similar (p = 0.315). Patients with HR-HPV-positive high-grade cervical dysplasia were at higher risk of 5-year recurrence (after primary conization) that HR-HPV-negative patients (p < 0.001, log-rank test). Via multi-variate analysis, HR-HPV-negative women were at low risk of recurrence (HR: 1.69 (95%CI: 1.05, 4.80); p = 0.018, Cox Hazard model). A propensity-score matched comparison was carried out in order to reduce biases that are related to the retrospective study design. In comparison to HR-HPV-negative patients, thosewith HR-HPV-positive CIN3 was associate with a 8-fold increase in the risk of recurrence (p < 0.001, log-rank test). Conclusions. HR-HPV-negative high-grade cervical dysplasia is not uncommon, accounting for 15% of our study population. Those patients experience more favorable outcomes than patients with documented HR-HPV infection(s). Further prospective studies are needed to corroborate our data. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [41] High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer
    Hesselink, Albertus T.
    Berkhof, Johannes
    Heideman, Danielle A. M.
    Bulkmans, Nicole W. J.
    van Tellingen, Jurjen E. H.
    Meijer, Chris J. L. M.
    Snijders, Peter J. F.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) : 381 - 386
  • [42] Nationwide cohort study on the risk of high-grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situ
    Schaafsma, Mirte
    Schuurman, Teska N.
    Kootstra, Pien
    Issa, Deli
    Hermans, Ivo
    Bleeker, Maaike C. G.
    Zusterzeel, Petra L. M.
    Bekkers, Ruud L. M.
    Siebers, Albert G.
    Mom, Constantijne H.
    van Trommel, Nienke E.
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (06) : 1203 - 1212
  • [43] VALUE OF HR-HPV DETECTION IN SCREENING OF CERVICAL LESIONS AND ANALYSIS OF RISK FACTORS OF HIGH-GRADE CERVICAL LESIONS
    Liu, Panpan
    Dou, Meifang
    Yi, Li'an
    Li, Kemei
    Yan, Fenghua
    ACTA MEDICA MEDITERRANEA, 2022, 38 (05): : 3187 - 3191
  • [44] High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions
    Lorenzi, Adriana T.
    Fregnani, Jose Humberto T.
    Dockter, Janel
    Fitzgerald, Kerry
    Strohecker, Elizabeth
    Eaton, Barbara
    Vibat, Cecile Rose T.
    Erlander, Mark G.
    Scapulatempo-Neto, Cristovam
    Smith, Jennifer S.
    Longatto-Filho, Adhemar
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (01) : 17 - 20
  • [45] Order of HPV/Chlamydia infections and cervical high-grade precancer risk: A case-cohort study
    Luostarinen, Tapio
    Namujju, Proscovia B.
    Merikukka, Marko
    Dillner, Joakim
    Hakulinen, Timo
    Koskela, Pentti
    Paavonen, Jorma
    Surcel, Helja-Marja
    Lehtinen, Matti
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (07) : 1756 - 1759
  • [46] The relationship between syntactic structure analysis features, histological grade and high-risk HPV DNA in cervical intraepithelial neoplasia
    Kruse, AJ
    Buhr-Wildhagen, S
    Janssen, EA
    Baak, JPA
    CELLULAR ONCOLOGY, 2004, 26 (03) : 135 - 141
  • [47] Implementation of a Screening Program for High-Grade Anal Dysplasia in High-Risk Patients in a Tertiary Cancer Center
    Araujo, Rodrigo Otavio de Castro
    Valadao, Marcus
    da Cunha e Silva, Jose Antonio Dias
    Lintomen, Leticia
    Garrido, Marianne Monteiro
    Barbosa, Pedro Lucas de Mendonca
    Piragibe, Maria Midori Miura
    Carvalho, Keyla Maciel
    Jay, Naomi
    Leal, Fabio Eudes
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [48] Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study
    Fischer, A. K.
    Reuter-Jessen, K.
    Schildhaus, H-U
    Hugo, T.
    Scheel, A. H.
    Merkelbach-Bruse, S.
    Heinmoeller, E.
    Buettner, R.
    Jasani, B.
    Walbeck, J.
    Rueschoff, J.
    Middell, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 80 - 84
  • [49] p16INK4a Is Superior to High-Risk Human Papillomavirus Testing in Cervical Cytology for the Prediction of Underlying High-Grade Dysplasia
    Samarawardana, Panduka
    Dehn, Donna L.
    Singh, Meenakshi
    Franquemont, Douglas
    Thompson, Chesney
    Gaido, Loretta
    Torkko, Kathleen C.
    Homer, Petra
    Burke, Stephanie
    Titmus, Matthew A.
    Nayi, Vipul
    Shroyer, Kenneth R.
    CANCER CYTOPATHOLOGY, 2010, 118 (03) : 146 - 156
  • [50] Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia
    Trope, Ameli
    Jonassen, Christine M.
    Sjoborg, Katrine D.
    Nygard, Mari
    Dahl, Fredrik A.
    Alfsen, G. Cecilie
    Lie, A. Kathrine
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 257 - 262